Stay updated with breaking news from Amarin Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amarin Co. plc (NASDAQ:AMRN – Free Report) – Investment analysts at Zacks Research lowered their Q3 2024 earnings per share estimates for shares of Amarin in a research report issued to clients and investors on Wednesday, May 15th. Zacks Research analyst R. Department now expects that the biopharmaceutical company will post earnings of ($0.06) per […]
Amarin Co. plc (NASDAQ:AMRN – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 15,840,000 shares, a decrease of 12.1% from the March 31st total of 18,020,000 shares. Based on an average trading volume of 1,680,000 shares, […]
Cutter & CO Brokerage Inc. decreased its position in Amarin Co. plc (NASDAQ:AMRN – Free Report) by 17.2% during the fourth quarter, Holdings Channel reports. The firm owned 441,601 shares of the biopharmaceutical company’s stock after selling 91,850 shares during the quarter. Cutter & CO Brokerage Inc.’s holdings in Amarin were worth $384,000 at the […]
Cutter & CO Brokerage Inc. trimmed its holdings in Amarin Co. plc (NASDAQ:AMRN – Free Report) by 17.2% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 441,601 shares of the biopharmaceutical company’s stock after selling 91,850 shares during the quarter. Cutter & CO Brokerage Inc. owned […]
Amarin Co. plc (NASDAQ:AMRN – Get Free Report) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 18,190,000 shares, an increase of 7.1% from the February 29th total of 16,990,000 shares. Based on an average trading volume of 2,310,000 shares, the days-to-cover ratio […]